Replies to post #4505 on Cel Sci Corporation (CVM)

[drkazmd65]

Agreed Nschai1 - one of the side effects of moving ponderously toward approval (& methodically IMO) is that if/when the Phase III trials are completed here CVM will have the capibility to produce Multikine in sufficient quantity to satisfy short-term demand.

Also via their associates in Isreal and Taiwan CVM will have access to facilities and distribution networks overseas in short-order should all go to plan.

If (and it does remain an if - if not an extremely big gamble) the trials go as planned with success in treatment demonstrated,... the take-off should be fairly abrupt and much smoother than Dendreon experienced.